{"id":401674,"date":"2025-11-24T16:38:16","date_gmt":"2025-11-24T16:38:16","guid":{"rendered":"https:\/\/www.europesays.com\/us\/401674\/"},"modified":"2025-11-24T16:38:16","modified_gmt":"2025-11-24T16:38:16","slug":"heart-condition-treatment-developed-by-phoenix-doctor","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/401674\/","title":{"rendered":"Heart condition treatment developed by Phoenix doctor"},"content":{"rendered":"<\/p>\n<p>PHOENIX \u2014 Imagine having a heart condition so severe you can\u2019t walk to your mailbox \u2014 and then being told you\u2019re too sick for treatment.<\/p>\n<p>That\u2019s been the reality for thousands of people suffering from mitral annular calcification, or MAC, a dangerous and worsening calcium buildup around the heart valve affecting roughly 30% of older adults. Traditional open-heart surgery can be life-threatening for patients with MAC, but a new procedure is changing that.<\/p>\n<p>\t\t\t<a href=\"https:\/\/ktar.com\/wp-content\/uploads\/2025\/11\/Dr-Sorajja-Headshot.jpg\" data-sub-html=\"Dr. Paul Sorajja helped develop live-saving treatment for a dangerous heart condition called MAC. (Banner Health photo)\" aria-label=\"Dr. Paul Sorajja helped develop live-saving treatment for a dangerous heart condition called MAC. (Banner Health photo)\" target=\"_blank\" rel=\"noopener\"><br \/>\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/11\/Dr-Sorajja-Headshot-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"Dr. Paul Sorajja helped develop live-saving treatment for a dangerous heart condition called MAC. (Banner Health photo)\"\/>\t\t<\/a><\/p>\n<p>In 2016, <a href=\"https:\/\/doctors.bannerhealth.com\/provider\/paul-sorajja\/5843997\" target=\"_blank\" rel=\"noopener\">Dr. Paul Sorajja<\/a> with Banner University Medical Center Phoenix became the first doctor in the world to use a specialized device called <a href=\"https:\/\/www.cardiovascular.abbott\/int\/en\/hcp\/products\/structural-heart\/tendyne-mitral-valve.html\" target=\"_blank\" rel=\"noopener\">Tendyne<\/a> to treat a patient with MAC. He then went on to lead the study that got the procedure <a href=\"https:\/\/www.bannerhealth.com\/newsroom\/press-releases\/dr-sorajja-tendyne\" target=\"_blank\" rel=\"noopener\">approved by the FDA<\/a> this year.<\/p>\n<p>\u201cThe heart never stops. There\u2019s no heart-lung machine,\u201d Sorajja said. \u201cIt doesn\u2019t require any cutting or sewing into the calcification of the valve, which makes it a very safe procedure.\u201d<\/p>\n<p>How does new treatment for heart condition work?<\/p>\n<p>The procedure replaces a leaky heart valve with the Tendyne device through a small incision between the ribs. The device expands inside the MAC patient\u2019s existing valve to stop leakage.<\/p>\n<p>Previous treatment options for the heart condition were far riskier. Surgeons would try to cut or remove the calcification through open-heart surgery, but that often led to fatal tears or leaks. Some even tried using off-label valves not designed for MAC, and patients frequently died.<\/p>\n<p>\u201cIn the previous experiences, the risk of death with traditional surgery was 8% to 10% or more. With the off-label valve therapies that people were trying, the risk of death was as high as 25%. With this new technology, we are now down into the 6% range, which is a lot more favorable for these patients,\u201d Sorajja said.<\/p>\n<p>For Sorajaa, the impact on patients has been indisputable.<\/p>\n<p>\u201cThey\u2019re just really grateful for the years they\u2019ve been given,\u201d he said. \u201cYou can think of it as if you had cancer or something life-threatening, and then somebody shows up with a drug that saves your life \u2014 it\u2019s akin to that. It\u2019s lifesaving and life-changing.\u201d<\/p>\n<p>He said the study showed the procedure was effective in 95% of cases \u2014 with nearly all patients reporting an improvement in their symptoms and quality of life.<\/p>\n<p>We want to hear from you.<\/p>\n<p style=\"margin-top: 0px;\">Have a story idea or tip? Pass it along to the KTAR News team <a href=\"https:\/\/ktar.com\/arizona-health-news\/heart-condition-mac-treatment\/5782026\/mailto:stories@ktar.com\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n<p><a href=\"https:\/\/ktar.com\/newsletters\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/08\/KTAREmail-830x100-1.jpg\" style=\"margin: 0 auto;\" class=\"mobile-signup\"\/>\t&#13;<br \/>\n\t<img decoding=\"async\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/08\/KTAREmail-830x100-1.jpg\" style=\"margin: 0 auto;\" class=\"desktop-signup\"\/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"PHOENIX \u2014 Imagine having a heart condition so severe you can\u2019t walk to your mailbox \u2014 and then&hellip;\n","protected":false},"author":3,"featured_media":401675,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5131],"tags":[7155,5229,5643,1587,316,1589,7154,67,586,132,5230,68,2969],"class_list":{"0":"post-401674","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-phoenix","8":"tag-92-3-ktar","9":"tag-america","10":"tag-arizona","11":"tag-az","12":"tag-home","13":"tag-phoenix","14":"tag-phoenix-and-arizona-breaking-news-and-news-headlines-home","15":"tag-united-states","16":"tag-united-states-of-america","17":"tag-unitedstates","18":"tag-unitedstatesofamerica","19":"tag-us","20":"tag-usa"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115605662254772740","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/401674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=401674"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/401674\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/401675"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=401674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=401674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=401674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}